Details for New Drug Application (NDA): 215721
✉ Email this page to a colleague
The generic ingredient in ZOLPIDEM TARTRATE is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.
Summary for 215721
Tradename: | ZOLPIDEM TARTRATE |
Applicant: | Almatica |
Ingredient: | zolpidem tartrate |
Patents: | 0 |
Pharmacology for NDA: 215721
Mechanism of Action | GABA A Receptor Positive Modulators |
Physiological Effect | Central Nervous System Depression |
Suppliers and Packaging for NDA: 215721
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZOLPIDEM TARTRATE | zolpidem tartrate | CAPSULE;ORAL | 215721 | NDA | Almatica Pharma LLC | 52427-775 | 52427-775-30 | 30 CAPSULE in 1 BOTTLE (52427-775-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 7.5MG | ||||
Approval Date: | May 9, 2023 | TE: | RLD: | Yes |
Complete Access Available with Subscription